Article thumbnail

Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation

By Luis MA Oliveira, Ana Lages, Ricardo A Gomes, Henrique Neves, Carlos Família, Ana V Coelho and Alexandre Quintas
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3175161
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1994). A: Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
  2. (1992). A: Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol
  3. (1994). Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
  4. (1995). Advanced protein glycosylation in diabetes and aging. Annu Rev Med
  5. (2004). an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic acids research
  6. (1994). Analysis of microtubuleassociated protein tau glycation in paired helical filaments.
  7. (1999). Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins
  8. (2005). AP: Protein glycation in Saccharomyces cerevisiae. Argpyrimidine formation and methylglyoxal catabolism.
  9. (1999). Biere AL: alphasynuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson’s disease.
  10. (2001). Biochemistry and molecular cell biology of diabetic complications.
  11. (2000). Carbonyl stress’ and dialysisrelated amyloidosis. Nephrol Dial Transplant
  12. (2000). CC: Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry
  13. (2000). Crosslinking of alpha-synuclein by advanced glycation endproducts–an early pathophysiological step in Lewy body formation?
  14. (1995). Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci
  15. (1986). Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods in enzymology
  16. (2002). DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics
  17. (2007). Different species of alpha-synuclein oligomers induce calcium influx and seeding.
  18. (1997). E: Toward understanding insulin fibrillation.
  19. (2005). Early events in the fibrillation of monomeric insulin.
  20. (1996). Flatt PR: Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes
  21. (1996). FM: Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysinelysine cross-link derived from methylglyoxal.
  22. (2009). Formation mechanism of insulin fibrils and structural aspects of the insulin fibrillation process. Curr Protein Pept Sci
  23. (1987). Galenics of insulin. The physicochemical and pharmaceutical aspects of insulin and insulin preparations.
  24. (1997). GB: Kinetic theory of fibrillogenesis of amyloid beta-protein.
  25. (1999). Gejyo F: Modification of beta 2-microglobulin with D-glucose or 3-deoxyglucosone inhibits A beta 2M amyloid fibril extension in vitro. Amyloid
  26. (1999). Glucose transporters and insulin action– implications for insulin resistance and diabetes mellitus.
  27. (1994). Glycated tau protein in Alzheimer’s disease: a mechanism for induction of oxidant stress.
  28. (1996). Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res
  29. (1995). Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.
  30. (2008). Inflammation and the redoxsensitive AGE-RAGE pathway as a therapeutic target in Alzheimer’s disease.
  31. (1991). Insulin action 1991. Clin Endocrinol (Oxf)
  32. (2000). Insulin action and insulin resistance in human skeletal muscle. Diabetologia
  33. (2005). Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease. Neuroscience
  34. (1991). JW: Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes
  35. (1983). Kashiwagi S: Iatrogenic, insulindependent, local amyloidosis. Lab Invest
  36. (1992). Lansbury PT Jr: Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry
  37. (2006). Lansbury PT Jr: Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys
  38. (1993). Lansbury PT Jr: Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell
  39. (2003). Lansbury PT: Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci
  40. (2009). Mass spectrometry characterization of the glycation sites of bovine insulin by tandem mass spectrometry.
  41. (1993). Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans
  42. (1972). Mercola DA: Three-dimensional atomic structure of insulin and its relationship to activity. Diabetes
  43. (2009). Molecular basis for insulin fibril assembly.
  44. (2007). Morozova-Roche LA: Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson’s disease patients.
  45. (1999). Nagaraj RH: Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys
  46. (2006). Nawroth PP: RAGE in inflammation: a new therapeutic target? Curr Opin Investig Drugs
  47. (1988). NM: The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci
  48. (2006). PH: Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
  49. (1988). PJ: Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia
  50. (2008). Ponces Freire A, Cordeiro C: Protein glycation in vivo: functional and structural effects on yeast enolase.
  51. (2005). Ponces Freire A: Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.
  52. (2001). Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry
  53. (1999). Quon MJ: Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal
  54. (2010). Ribosylation rapidly induces alphasynuclein to form highly cytotoxic molten globules of advanced glycation end products. PLoS One
  55. (2004). Role for glyoxalase I in Alzheimer’s disease. Proc Natl Acad Sci USA
  56. (2002). Saibil HR: The protofilament structure of insulin amyloid fibrils.
  57. (1988). Santoro MM: Unfolding free energy changes determined by the linear extrapolation method. 2. Incorporation of delta G degrees N-U values in a thermodynamic cycle. Biochemistry
  58. (2005). Sipe JD: Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid
  59. (2009). SM: Cellular prion protein mediates impairment of synaptic plasticity by amyloidbeta oligomers. Nature
  60. (2006). Structural and functional changes in human insulin induced by methylglyoxal.
  61. (1979). Studies and critique of Amido Black 10B, Coomassie Blue R, and Fast Green FCF as stains for proteins after polyacrylamide gel electrophoresis. Analytical biochemistry
  62. (2007). Svergun DI: A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol
  63. (1989). Takeda T: Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Analytical biochemistry
  64. (1990). Takeda T: Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T. Lab Invest
  65. (2002). Tekoppel JM: Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum
  66. (2009). The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process. Biochim Biophys Acta
  67. (1994). Thornalley PJ: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin.
  68. (2005). Thornalley PJ: Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo.
  69. (2000). Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide.
  70. (1988). Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry
  71. (2008). Uversky VN: Guiding protein aggregation with macromolecular crowding. Biochemistry